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INTRODUCTION 
 Prior to the introduction of extracorporeal shockwave lithotripsy 
(ESWL) in 1980, the only treatment available for calculi that could not 
pass through the urinary tract was open surgery. Since then, ESWL has 
become the preferred tool in the urologist’s armamentarium for the 
treatment of renal stones, proximal stones, and midureteral stones. 
Compared with open and endoscopic procedures, ESWL is minimally 
invasive, exposes patients to less anaesthesia, and yields equivalent stone-
free rates in appropriately selected patients.  
The efficacy of ESWL lies in its ability to pulverize calculi in vivo 
into smaller fragments, which the body can then expulse spontaneously. 
Shockwaves are generated and then focused onto a point within the body. 
The shockwaves propagate through the body with negligible dissipation 
of energy (and therefore damage) owing to the minimal difference in 
density of the soft tissues. At the stone-fluid interface, the relatively large 
difference in density, coupled with the concentration of multiple 
shockwaves in a small area, produces a large dissipation of energy. Via 
various mechanisms, this energy is then able to overcome the tensile 
strength of the calculi, leading to fragmentation. Repetition of this 
process eventually leads to pulverization of the calculi into small 
fragments (ideally <1 mm) that the body can be passed spontaneously. 
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The lifetime prevalence of kidney stone disease is 1-15% with the 
probability of having a stone varying according to age, gender, race, and 
geographic location. Management of renal calculi has changed 
dramatically during the past 30 years.  
Minimally invasive techniques especially the introduction and 
development of Extra Corporeal Shock Wave Lithotripsy (ESWL) 
virtually have replaced open surgical stone removal. ESWL was 
introduced by Christian Chaussay in 1980. 80-85% of simple renal 
calculi can be treated effectively with non invasive ESWL and won the 
Nobel prize.  
ESWL is a non invasive therapy for urinary calculi with good 
success rates with decreased morbidity, length of hospitalization and 
anaesthesia requirement. According to AUA guidelines ESWL is the 
preferred modality of treatment for renal stones  of < 2 cm in size. 
Even large and complex renal calculi may be treated effectively 
with these minimally invasive techniques. For complete staghorn calculi a 
combined PCNL and ESWL (Sandwich) therapy have been 
recommended as the first line of treatment. 
However even for the calculi of this size, the stone free rates vary 
between 66% - 99%. This variation in stone fragmentation is due to 
factors like size, stone location, chemical composition, BMI, other 
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congenital anatomical anomalies, shock wave generator and presence of 
obstruction (or) infection. 
The renal calyces are the most common location of asymptomatic 
(or) incidentally discovered urinary calculi. Pelvic calculi, upper calyceal 
and middle calyceal stones of less than 2cm have been treated with 
ESWL with stone free rate of upto 99%.  
The management of lower calyceal stone is more controversial and 
in this situation stone free rate after ESWL range from 44-79% (4 & 5). 
Lower calyceal stone with favourable infundibulo pelvic anatomy have 
good success rate with ESWL. 
Stone fragmentation by ESWL is variable. So it is desirable to 
reduce the number of retreatment (or) limit the therapy to one definite 
therapy. In addition, the local effects of ESWL upon renal parenchyma 
and surrounding organs are also of concern. The long term prevalence 
rate of HT and change in renal plasma flow following ESWL treatment 
constitute a further reason for the surgeon to limit the therapy to one 
definite treatment. The success of ESWL has been correlated with 
radiodensity of the renal stone on plain X-ray KUB. Overall accuracy of 
predicting calculi composition from plain radiographs was reported to be 
only 39% which is at present insufficient for clinical use. 
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The Emergence of Non Contrast CT KUB in the assessment of 
flank pain and the subsequent availability of the attenuation coefficient 
measurement has interacted several groups in comparing attenuation and 
stone composition invitro.  These studies have determined that stone 
compositions can be predicted on the basis of the attenuation value 
determined by NCCT. 
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REVIEW OF LITERATURE 
The prevalence of stone disease is very high in most parts of India 
because of its geography, dietary habits, temperature and humidity 
superimposed on their intrinsic factors predisposing to stone formation.  
Prevalence of stone disease ranges from 1-15% and varies by age, sex 
and race. For men incidence begins to rise after age 20, peaks between 40 
and 60 years at about 3/1000/y and then begin to decline. For women 
incidence rates seem to be higher in late 20s (2.5/1000/y) and then 
decreasing to 1/1000/y age 50. The increased incidence and prevalence of 
stone disease in recent years, may  be from increased detection of 
asymptomatic stones discovered with the greater use and higher 
sensitivity of imaging studies. 
Stone disease can be easily diagnosed using imaging studies X-ray 
KUB, USG KUB and IVU, CT KUB. Plain radiography detects radio 
opaque calculi. The limitations are bowel gas, bone shadow overlapping 
and cannot detect radiolucent stones. 
USG KUB can detect calculi in the renal area and associated 
obstruction and dilatation of pelvi calyceal system. The limitations in the 
images are obesity, bowel gas and ureteric calculi. 
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Non contrast CT KUB is a simple method to detect renal and 
ureteric calculi,  assess stone burden with density, assess the stone  
number, stone location and dilatation of pelvicalyceal system. 
Various treatment options which are non invasive and other 
minimally invasive surgeries have replaced the open stone surgery 
nowadays. Extra Corporeal Shockwave Lithotripsy is a non invasive 
treatment option with minimal morbidity.  
The  word Lithotriptor is of Greek origin and means stone crusher. 
Lithotriptors have evolved from many years of research in physics of 
flight. Researchers discovered that raindrops striking an air craft during 
supersonic flight created shockwaves that had disintegrating effects on 
solid materials. Refinements of these findings led to the intervention of 
the lithotriptor as a means for treating urinary calculi. 
In February 1980 Dr. Christian Chaussay, University of Munich 
first used electrically generated focused shockwaves to fragment stones 
within a human kidney. The first experimental treatment began the era of 
ESWL. The first Lithotriptor model HM 1 soon replaced by HM 2 in 
1982 and in 1984 by Model HM 3. Each new generation reflects 
progression of technology and a growing sophistication. Further 
modification of the generation is the consolidation of fluoroscopic 
screens and the lithotripsy control into a convenient, efficient and user 
friendly console. Shockwave lithotripsy technology has advanced rapidly 
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in terms of shock wave generation, focusing, patient coupling and stone 
localization making it the most widely used treatment for renal calculi. 
Methods of Shock Wave Generation 
Lithotripters, are characterized by the type of shockwave 
generators they employ. Commercially available lithotripters use Electro 
hydraulic (EH),  Electromagnetic (EM) and Piezoelectric generators . 
Electro Hydraulic (Spark Gap) Generators 
The original method of shockwave generation (used in the Dornier 
HM3) was electro hydraulic, meaning that the shockwave is produced via 
spark-gap technology. In an electro hydraulic generator, a high-voltage 
electrical current passes across a spark-gap electrode located within a 
water-filled container. The discharge of energy produces a vaporization 
bubble, which expands and immediately collapses, thus generating a 
high-energy pressure wave. 
A spherically expanding shockwave is generated by an underwater 
spark discharge (15000-25000V) Electrode at F1 and focused by hemi 
ellipsoid reflector and focused on to calculus F2. Advantage of this 
generator is effectiveness in breaking kidney stones. Disadvantages are 
substantial pressure fluctuations from shock to shock and  a relatively 
short electrode life.  
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Electromagnetic Generators 
In an electromagnetic generator, a high voltage is applied to an 
electromagnetic coil, similar to the effect in a stereo loudspeaker. This 
coil, either directly or via a secondary coil, induces high-frequency 
vibration in an adjacent metallic membrane. This vibration is then 
transferred to a wave-propagating medium (ie, water) to produce 
shockwaves. 
EMSE - Electromagnetic shock wave Emitter. The disk coil is 
charged with high voltage pulses (5000-20000V) whereby the membrane 
lying directly on the coil is thrust outwards. The shock wave generated is 
focused by means of an acoustic lens. 
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Advantages 
 Electromagnetic Generators are more controllable and 
reproducible. Introduction of energy into patients body over a large skin 
area cause less pain, small focus can be achieved with high energy 
densities which may increase its effectiveness is breaking stones. 
Disadvantages 
  Small focal region of high energy reflects an increased rate of          
subcapsular hematoma formation. 
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Piezoelectric Generator 
The piezoelectric effect produces electricity via application of 
mechanical stress. The Curie brothers first demonstrated this in 1880. The 
following year, Gabriel Lippman theorized the reversibility of this effect, 
which was later confirmed by the Curie brothers. The piezoelectric 
generator takes advantage of this effect. Piezoelectric ceramics or 
crystals, set in a water-filled container, are stimulated via high-frequency 
electrical pulses. The alternating stress/strain changes in the material 
create ultrasonic vibrations, resulting in the production of a shockwave. 
Piezoelectric energy source uses a spherical array of piezoelectric 
crystals excited by electric impulse 2000-6000V, by simultaneous sudden 
expansion, shockwaves are generated and focused. 
Advantages 
 Focusing accuracy, a long service life, and anaesthesia free 
treatment. 
Disadvantages 
 Insufficient power it delivers hampers its ability to effectively 
break renal stones.  
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Focusing systems 
The focusing system is used to direct the generator-produced 
shockwaves at a focal volume in a synchronous fashion. The basic 
geometric principle used in most lithotripters is that of an ellipse. 
Shockwaves are created at one focal point (F1) and converge at the 
second focal point (F2). The target zone, or blast path, is the 3-
dimensional area at F2, where the shockwaves are concentrated and 
fragmentation occurs. 
Focusing systems differ, depending on the shockwave generator 
used. Electrohydraulic systems used the principle of the ellipse; a metal 
ellipsoid directs the energy created from the spark-gap electrode. In 
piezoelectric systems, ceramic crystals arranged within a hemispherical 
dish direct the produced energy toward a focal point. In electromagnetic 
systems, the shockwaves are focused with either an acoustic lens 
(Siemens system) or a cylindrical reflector (Storz system). 
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 Shock wave focusing allows for the concentration of shockwave 
energy at a focal point. The focal area refers to the volume within which 
the shock waves are concentrated. 
Coupling mechanisms 
In the propagation and transmission of a wave, energy is lost at 
interfaces with differing densities. As such, a coupling system is needed 
to minimize the dissipation of energy of a shockwave as it traverses the 
skin surface. The usual medium used is water, as this has a density 
similar to that of soft tissue and is readily available. In first-generation 
lithotriptors (Dornier HM3), the patient was placed in a water bath. 
However, with second- and third-generation lithotriptors, small water-
filled drums or cushions with a silicone membrane are used instead of 
large water baths to provide air-free contact with the patient's skin. This 
innovation facilitates the treatment of calculi in the kidney or the ureter, 
often with less anaesthesia than that required with the first-generation 
devices. 
 Shock waves can be coupled effectively into body by degassed 
water which has matched acoustic impedance to soft tissues. Current 
lithotripter use enclosed water cushion with a coupling medium of 
ultrasound gel instead of 1000 L water bath. Shock wave attenuation 
through the membrane of water cushion amounts to 20% loss of energy. 
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Localization systems 
Imaging systems are used to localize the stone and to direct the 
shockwaves onto the calculus, as well as to track the progress of 
treatment and to make alterations as the stone fragments. The two 
methods commonly used to localize stones include fluoroscopy and 
ultrasonography. 
Fluoroscopy, which is familiar to most urologists, involves 
ionizing radiation to visualize calculi. Disadvantages are Ionizing 
radiation to both the patient and medical staff, and it is not useful in 
localizing radiolucent calculi. As such, fluoroscopy is excellent for 
detecting and tracking calcified and otherwise radio-opaque stones, both 
in the kidney and the ureter. Conversely, it is usually poor for localizing 
radiolucent stones (eg, uric acid stones). To compensate for this 
shortcoming, intravenous contrast can be introduced or (more commonly) 
cannulation of the ureter with a catheter and retrograde instillation of 
contrast (ie retrograde pyelography) can be performed. 
Ultrasonographic localization allows for visualization of both radio 
opaque and radiolucent renal stones and the real-time monitoring of 
lithotripsy. Most second-generation lithotripters can use this imaging 
modality, which is much less expensive to use than radiographic systems. 
Although ultrasonography has the advantage of preventing exposure to 
ionizing radiation, it is technically limited by its ability to visualize 
ureteral calculi, typically due to interposed air-filled intestinal loops. In 
particular, smaller stones may be easy to localize accurately. 
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  Ultrasonography based lithotriptors offer the advantages of stone 
localization with continuous monitoring and can differentiate stent from 
stone in case of Renal calculus with stent.  
USG COMPATIBLE ESWL 
 
 
 
 
 
 
 
FLUOROSCOPY COMPATIBLE ESWL 
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History of the Procedure 
Evolution of shockwave lithotriptors 
The Dornier HM3, originally designed to test supersonic aircraft 
parts, was the first shockwave lithotripter introduced in the United States. 
Despite being somewhat out dated, it is still one of the most effective 
lithotripters and has become the standard to which other devices are 
compared. The design of the HM3 is based on an electrohydraulic 
shockwave generator; the shockwaves are focused via an ellipsoid metal 
water-filled tub in which both the patient and the generator are 
submerged. Biplanar fluoroscopy is used for localization, allowing 
placement of the calculi to be fragmented in the target zone. 
Second-generation lithotripters typically use piezoelectric or 
electromagnetic generators as the energy source. When coupled with the 
appropriate focusing device, these shockwave generators commonly have 
a smaller focal zone. Although a smaller focal zone may minimize 
damage to the surrounding tissue, this comes at a price. During 
respiratory excursion, the stone may move in and out of the focal zone; 
this may compromise fragmentation rates. The coupling device in a 
second-generation lithotripter is a silicone-encased water cushion that 
coapts to the patient, a design that greatly simplifies the positioning of 
patients. 
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The new generation lithotripters have been designed to offer 
greater portability and adaptability. These systems often provide imaging 
with both fluoroscopy and ultrasonography. The ability to alternate 
between imaging modalities allows the urologist to compensate for the 
deficiencies of either system. 
Most current lithotripters are powered by an electromagnetic 
generator. Electromagnetic generators and their focusing units are 
capable of delivering shockwaves that are similar in intensity to those of 
the HM3, but usually to a smaller focal zone. As mentioned above, this 
has the theoretical advantage of minimizing damage to surrounding soft 
tissue. However, because of the smaller focal zone, respiration may cause 
the stone to move out of the target zone for portions of the treatment. 
Although improved localization techniques and anesthetic manipulation 
can be used to account for this, the shockwaves applied while the stones 
are out of the target zone do not cause fragmentation. Thus, certain 
second and third-generation machines are associated with higher failure 
rates, incomplete treatment and the need for retreatment. 
Pathophysiology 
A stone is fragmented when the force of the shockwaves 
overcomes the tensile strength of the stone. Although incompletely 
understood, fragmentation is thought to occur through a combination of 
methods, including compressive and tensile forces, erosion, shearing, 
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spalling, and cavitation. Of these various forces, the generation of 
compressive and tensile forces and cavitation are thought to be the most 
important. 
When a shockwave is propagated through a medium (water), it 
loses very little energy until it crosses into a medium with a different 
density. If the medium is denser, compressive forces are produced on the 
new medium. Similarly, if the new medium is less dense, tensile stress is 
produced on the first medium. Upon hitting the anterior surface of a 
stone, the change in density creates compressive forces, causing 
fragmentation. As the wave proceeds through the stone to the posterior 
surface, the change from high to low density reflects part of the 
shockwave’s energy, producing tensile forces, which again disrupt and 
fragment the stone. 
In cavitation, shockwave energy applied at a focal point leads to 
failure of the liquid with generation of water-vapor bubbles. These 
gaseous bubbles collapse explosively, creating microjets that fracture and 
erode the calculus. This process can be monitored with real-time 
ultrasonography during the treatment and appears as swirling fragments 
and liquid in the focal zone. 
Physical properties of renal calculi and tissue 
 Knowledge of acoustic and mechanical properties of renal calculi 
and tissue is important to understand shockwave – stone tissue interaction 
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and the mechanisms of stone fragmentation and tissue injury during 
ESWL Acoustic properties determine the characteristics of shock wave 
propagation inside the stone and tissue materials as well as the wave 
transmission and reflection, at the stone tissue boundary. Mechanical 
properties dictate the response of the stone and tissue materials to shock 
wave loadings. Acoustic and mechanical properties of renal calculi 
depend primarily on the composition of stone. 
Composition  and structural features of renal calculi 
 The constituents of renal calculi are crystalline (95%) and non 
crystalline matrix materials (Protein, Cellular debris and organic 
materials) 
Major crystalline components are calcium oxalate (Monohydrate 
and dihydrate) phosphates (hydroxyapatite, carbonate apatite struvite) 
uric acid, urate, cystine and xanthine. Renal calculi appear in wide range 
of shapes, sizes, colors and textures.  
Acoustic properties of renal calculi and renal tissue 
 Acoustic properties are density, wave speed and acoustic 
impedance. Longitudinal wave propagation (compressional) characterized 
by parallel movements of material particles along the wave path. 
Transverse (Shear) wave propagation material particles move 
perpendicularly to wave path. 
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Calcium oxalate monohydrate and cystine stones have higher 
acoustic impedance. Stones with higher acoustic impedance would 
produce a stronger reflection of the shock wave at the anterior surface of 
stone resulting in less of the shock wave energy being transmitted into the 
stone to cause fragmentation. 
Mechanical properties of renal calculi 
 Dynamic elastic properties of renal calculi depends upon resistance 
of stone material to elongation (or) shortening, shear deformation and 
volume change. Most renal calculi are brittle while cystine stones are 
ductile (more energy is needed to produce fracture) so most difficult to 
fragment during SWL. 
Mechanisms of varying stone fragility 
 Stone fragility determines the response of a renal calculus to SWL 
therapy varies  with composition,  size, structural features of stone. 
 It has been reported that stone with homogenous structure are less 
fragile than stones with heterogenous structure. Most renal calculi are 
found to be brittle except cystine stones which are ductile. Elastic module 
determine a stones resistance to shock wave induced deformation, 
hardness determine a stone’s resistance to cavitation, microjet impact and 
fracture toughness determines a stone’s resistance to spalling damage and 
crack propagation. COM(Calcium oxalate monohydrate) and brushite 
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stones are less fragile than MAP(Magnesium ammonium phosphates) and 
CA(Carboxy apatite) stones because COM and brushite stones are stiffer, 
harder and more resistant to fracture.  
Modes of stone fragmentation  
 Stone fragmentation vary depending on composition, size and 
structural features. 
 Damage methods are surface erosion at the anterior surface of 
stone, spalling damage at the posterior surface of stone and layer 
separation at the interface of adjacent stone laminar surface. 
 Shock waves produce bubbles 100-200 s size collapse rapidly 
near the stone surface, produce high speed microjet (770 m/s) impinge 
towards the stone surface to cause damage. 
 Anterior surface of stone numerous minute pits are formed and 
characteristic of cavitation induced surface erosion. 
 Spalling damage a separation of spherical cap from posterior 
surface of stone produced by reflected tensile waves. This mode of stone 
damage can be attributed to the reflected tensile waves generated at the 
layer interface because of acoustic impedance mismatch between stone 
crystalline and surrounding matrix materials. Numerous micro fracture 
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grow and propagate to form large crack lines leading to stone 
disintegration.  
 
 The ultimate goal  of ESWL is to fragment renal and ureteric 
calculi as effectively as possible with minimizing the potential injury to 
surrounding tissues. 
Mechanisms of stone fragmentation 
 Calculi maintain their form because of innate comprehensive 
forces. Fragmentation occurs when tensile strength of a calculus is 
overcome by opposing force created by shockwaves. Stone fragmentation 
occurs by several mechanisms. 
Shock Waves composed of positive compressive waves and 
negative tensile waves. 
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 Stone fragmentation varies according to stone composition cystine 
stones are most ESWL resistant. Next are Brushite, and Calcium Oxalate 
Monohydrate. Pre treatment determination of stone composition and an 
ability to predict the  probability of fragmentation can reduce the number 
of fruitless shockwaves and reduce the overall cost of stone management.  
 Different techniques have been used to assist in determining the 
chemical composition of urinary calculi in vivo.  Such tests include pH, 
identifying characterizing urinary crystals. The presence of urea splitting 
organisms, bone densitometry  and radiographic studies. 
 Roentgenography has played a major role in the diagnosis and 
management of calculus disease. Various researchers have attempted to 
predict the stone composition by different methods. 
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Dretler pioneered the work on stone fragility and the magnitude of 
response of a calculus to stone fragmentation techniques. The author 
chooses 6 calculi with near 100% purity. These were photographed on 
high resolution roentgenographic paper to compare the crystal structure 
and allow appreciation of differences in their structure. Small spalls are 
noted in the calcium oxalate dehydrate COD stone. Whereas the 
appearance of calcium oxalate monohydrate and Brushite stones are more 
uniformly dense. Struvite calculi show alternating lines of dense and less 
opaque material. Cystine and uric acid calculi have more homogenous 
structure, without obvious striations. They concluded that except of 
cystine calculi radiologic density correlated well with stone fragility (22). 
In 1996 Dretler and Kolt (23) further analyzed radiographic 
patterns of calcium oxalate dihydrate and monohydrate stones. Smooth 
edge, denser than bone, homogenous are pure calcium oxalate 
monohydrate stones. Radial striations and superimposed stippling pattern 
in calcium oxalate dihydrate stones. This study is the first proof that 
radiographic morphology can be related to ESWL stone free rate.   
 Bone et al (7) demonstrated that a smooth, denser than bone                 
calcium oxalate monohydrate stone, fragments less efficiently than rough 
less dense calcium oxalate dihydrate stone. 
Plain radiographs have many limitations. For distinct outline of the 
renal stone it should be of more than 1cm size. Moreover the stone may 
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get masked by overlying bowel gas and for obvious appearance it should 
be located in an area away from bony structures. 
 Cohen et al showed that an accurate diagnosis of stone 
composition could be made by an analysis of crystals in post ESWL urine 
specimen using scanning Electron Microscopy and X-ray energy 
dispersive spectroscopy (XES) then his associates extended the use of 
these techniques to include examination of pre treatment urine specimen, 
and thereby predicting the response to ESWL success.  The disadvantage 
of this method include unavailability of a Electron Microscopic urine 
examination and difficulty in predicting the nature of calculi in patients 
with mixed stones.  
 Cher Saw et al studied the ability of stone density on non contrast 
CT to predict the number of shock waves required for fragmentation of 
stones. 
 CT 120 KV 80mA 3mm Collimation)  
 The number of shock waves required for fragmentation to less than 
3mm was taken as the end point. However due to technical defect of 
volume averaging with 3mm collimation the correlation was not due to 
radiological density but rather solely to stone size. They concluded that 
the size and not HU which determined the number of shockwaves 
required for fragmentation. 
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 CT Scan is a relatively simple and non invasive technique that is 
available in most medical centres. Radio opaque and radiolucent calculi  
can be detected. Several reports have indicated that with the use of 
modern instrumentation uric acid and poorly mineralized matrix stones 
can be identified with certainty. 
 Hillman and his associate sought to determine the feasibility of 
using CT to analyse the chemical composition of renal calculi. He 
concluded that uric acid stone can be differentiated clearly from struvite 
and calcium oxalate calculi.   
(CT number (or) Hounsfield unit is calculated using the formula). 
1000 x  tissue  --  water 
 Water 
 
  - absorption coefficient in kilovoltage. This number is named in 
honor of Godfrey Hounsfield the inventor of CT Scanning when HUs are 
used air has a value of – 1000,  water- 0 and dense bone and calcification              
> + 1000. 
 Federle et al (30) evaluated 9 Patients and analysed CT HU with 
stone composition. In this study 1 uric acid stone has an attenuation value 
between 346-400 HU, Xanthine stone had a value of 391 HU, cystine 
stone 586 HU, calcium oxalate 500-1000 HU. 
 Kuwahara et al (31) studied the attenuation value of CT of 50 
calculi more than 1cm in diameter to determine its composition. The 
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attenuation of various calculi were measured in HU in 5mm collimation 
in the region of interest. Values obtained as follows. Mixed calcium 
oxalate Phosphate 1555+193, Magnesium Ammonium  Phosphate 
1285+284, calcium oxalate 1690, Calcium Phosphate 1440, Cystine 
757+114. Uric acid 480. They concluded that attenuation values ranging 
from 500-1600 overlapped for various calculi. However uric acid calculi 
had attenuation value less than 500 and oxalate calculi >1000. They could 
not find any correlation between the attenuation value and the mineral 
content.  
Indications 
The current options available for the treatment of renal and ureteral 
calculi include conservative management (watchful waiting for 
spontaneous passage), extracorporeal shockwave lithotripsy (ESWL), 
endoscopic techniques (rigid or flexible ureteroscopic lithotripsy), and 
percutaneous treatments.  
The American Urological Association Stone Guidelines Panel has 
classified ESWL as a potential first-line treatment for ureteral and renal 
stones smaller than 2 cm. 
Indications for ESWL include the following: 
 Individuals who work in professions in which unexpected 
symptoms of stone passage may prompt dangerous situations (eg, 
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pilots, military personnel, physicians) In such individuals, 
definitive management is preferred to prevent adverse outcomes.  
 Individuals with solitary kidneys in whom attempted conservative 
management and spontaneous passage of the stone may lead to an 
anuric state.  
 Patients with hypertension, diabetes, or other medical conditions 
that predispose to renal insufficiency. 
Contraindications 
Absolute contraindications to extracorporeal shockwave lithotripsy 
(ESWL) include the following: 
 Acute urinary tract infection or urosepsis  
 Uncorrected bleeding disorders or coagulopathies  
 Pregnancy  
 Uncorrected obstruction distal to the stone 
Relative contraindications include the following: 
 Body habitus: Morbid obesity and orthopedic or spinal deformities 
may complicate or prevent proper positioning. In these situations, 
attempting to position the patient prior to anesthetic induction is 
useful to ensure the practicality of the approach.  
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 Renal ectopy or malformations (eg, horseshoe kidneys and pelvic 
kidneys)  
 Complex intrarenal drainage (eg, infundibular stenosis)  
 Poorly controlled hypertension (due to increased bleeding risk)  
 Gastrointestinal disorders: In rare cases, these may be exacerbated 
after ESWL treatment.  
 Renal insufficiency: Stone-free rates in patients with renal 
insufficiency (57%) (serum creatinine level of 2–2.9 mg/dL) were 
significantly lower than in patients with better renal function (66%) 
(serum creatinine level <2 mg/dL). 
Preexisting pulmonary and cardiac problems are not 
contraindications, provided they are appropriately addressed both 
preoperatively and intraoperatively. In patients with a history of cardiac 
arrhythmias, the shockwave can be linked to electrocardiography (ECG), 
thus firing only on the R wave in the cardiac cycle (ie, gated lithotripsy).  
Cardiac pacemakers are also not contraindicated, although seeking 
assistance from a cardiologist for possible changes to pacemaker settings 
would be prudent.  
Oral anticoagulants (eg, clopidogrel [Plavix] and warfarin 
[Coumadin]) should be discontinued to allow normalization of clotting 
parameters. Platelet function is normalized by discontinuing aspirin-
containing products and nonsteroidal anti-inflammatory drugs (NSAIDs) 
7 days before treatment. 
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AIM AND OBJECTIVES 
 To compare the efficacy of localization and fragmentation of renal 
stone by USG and fluoroscopy  in ESWL based on  
1. Location 
2. Size 
3. Mean distance between skin and stone (Morbid Obesity) 
4. Radiolucency  
5. Anatomic factors 
6. Stent Placement  
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MATERIALS AND METHODS 
 
STUDY DESIGN 
This is a prospective study conducted in 110 patients of renal stone 
disease Based on ESWL done in department of urology, Govt. 
Royapettah Hospital and KMC Hospital, Chennai during the period 
January 2009 – January 2010. 
INCLUSION CRITERIA 
1. Patients with Renal stone 5mm – 2 cm in diameter in upper, middle  
calyx or Renal Pelvis and  1cm in lower calyx. Not an previously 
treated for the same. 
2. All stone located in a satisfactory functioning non obstructed Renal 
unit. 
EXCLUSION CRITERIA 
 Pediatric patients 
 Bleeding diathesis 
 Pregnant females 
 Uncontrolled infection 
 Ureteric calculi 
 Distal obstruction 
 Congenital Anomalies 
 Patients with cardiac pacemaker 
 Lower calyceal stone with unfavourable anatomy. 
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Limiting factor 
 Passing debris instead of stone Bits after/ during SWL. 
 Totally 110 cases were taken out of which 10 cases were 
eliminated because of previous surgery, co-morbid illness, old age, 100 
cases were selected. 
 Out of 100 cases 50 cases were allotted for USG guided ESWL and 
50 cases for fluoroscopy guided ESWL. 
 Based on stone factor 
1. Site 
2. Size 
3. Number  
Based on Clinical factor 
1. Skin – stone distance  10 cm 
Based on Anatomic factors  
1. Hydronephrosis 
2. Lower pole 
3. Solitary  
4. Ectopic 
 
 32 
In all patients History and Physical examination was done. 
Baseline investigations included were CBC, Urine Culture and Sensitive,  
X-ray KUB, USG KUB, CT – KUB. 
Preprocedure DJ stenting was done for 1.5 cm Stone size. 
Patients were explained about the study, ESWL procedure and 
informed consent obtained. 
ESWL was done as out patients. Patient datas were recorded in 
proforma. All treatments were done with Dornier compact Delta II 
Electromagnetic Generator Machine with 9 inches HF fluoroscopy and 10 
inches USG. 
Selected patients were administered sedation Tramadol 8 mg IV, 
10 min before procedure. Topical EMLA cream was used in some 
patients. 
 A minimum of 500 shocks and maximum of 2500 stocks were 
given in each sitting. 
 Intensity increased stepwise pattern 
 Shock frequency was 60/ min/ 
 For fluoroscopic Guided ESWL stone fragmentation monitored 
every 100 shocks. 
 For USG – continuous monitoring. 
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Adequate fragmentation was accepted when following were observed. 
1. Alteration in stone configuration. 
2. Increase in stone surface area 
3. Hydronephrosis in Non- hydronephrotic Renal unit (USG 
Guided) 
4. Obviously separated fragment 
5. Decreased overall density 
6. Irregularity in outline. 
Patients counseled about the procedure and explained about 
sedation effects, pain, haematuria and voiding of fragments and possible 
success rate and need for second sitting / treatment. 
After each session of treatment patients were observed for 2-3 
hours period & allowed to go home. 
Antibiotics, Analgesics and fluid intake of 3-5 l/day along with 
potassium citrate  syrup adviced. 
All patients were instructed to pass urine through sieve (coffee 
filter) and to collect stone fragments. This was brought to us in follow up 
for chemical analysis. 
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Post procedure follow-up 
 Patients followed up at 2 weeks with x-ray KUB, USG KUB and 
selected CT KUB in fluoro guided ESWL. 
 In USG Guided patients instructed about the fragmentation, stone 
clearance in patients with residual fragments patients were advised for II 
sitting ESWL on same day. 
 Residual calculi by X-ray, USG KUB and CT KUB < 5mm (CIRF) 
clinically insignificant residual fragment were considered adequately 
treated. Residual fragments > 5mm considered treatment failure. 
 The stone fragments brought by the Patients were collected, labeled 
and sent for chemical composition analysis, biochemistry dept, MMC (by 
chemical dissolution method stone composition was detected). 
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STONE  FRAGMENTATION GROUP 
PRE  ESWL     FLUORO FOCUSING 
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STONE  FRAGMENTATION GROUP 
PRE ESWL 
 
 
 
 
 
POST  ESWL 
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STONE WITH RESIDUAL FRAGMENTS (Failure of Treatment) 
PRE  ESWL 
 
 
 
 
 
POST ESWL 
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RESULTS & OBSERVATIONS 
50 patients for USG guided and 50 patients for fluoro guided under 
went ESWL who had satisfied the inclusion and exclusion criteria 
mentioned earlier and later underwent. 
USG / Fluoroscopy guided ESWL 
 Out of 100 patients 50 patients were taken for USG guided and 50 
patients were taken for fluoroscopy guided study. 
USG Fluoroscopy 
50 50 
 
 
USG/ FLUOROSCOPY GUIDED ESWL 
50 50 
USG 
G 
FLUOROSCOPY 
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SEX  DISTRIBUTION 
There were 55 Male Patients and 45 Female Patients in the study. 
MALE FEMALE 
55 45 
 
 
SEX DISTRIBUTION 
55 
45 
Male Female 
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AGE DISTRIBUTION 
0
5
10
15
20
25
30
35
40
45
50
< 25 Years 26 – 35 36 – 45 > 45
Age in Years
N
o
. 
o
f 
P
a
ti
e
n
ts
< 25 Years 26 – 35 36 – 45 > 45
AGE  DISTRIBUTION 
No of patients according to the age ranged from below 25 years 19  
patients, 26 – 35 years 46 patients, 36– 45 years 26 patients, > 45 years 9 
patients. 
Age No. of Patients 
< 25 Years 19 
26 – 35 46 
36 – 45 26 
> 45 9 
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SYMPTOM DISTRIBUTION 
 Majority of the patients (80%) presented with loin pain with or 
without associated symptoms. 
 10-15% of the patients presented without loin pain with other 
symptoms like dysuria, fever, vomiting. 
 5% of the patients were asymptomatic and incidentally detected. 
SYMPTOMS 
NO. OF 
PATIENTS 
PERCENTAGE 
Loin Pain 80 80% 
Other Symptoms 15 15% 
Asymptomatic / Incidental  5 5% 
 
SYMPTOM DISTRIBUTION
80%
15%
5%
Loin Pain Other Symptoms Asymptomatic/ Incidental
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RADIO – OPACITY DISTRIBUTION 
 Out of 100 patients included in the study 10% were radiolucent and 
90% were Radioopaque. 
Radiolucent Radioopaque 
10 90 
 
RADIO-OPACITY DISTRIBUTION
10%
90%
Radiolucent Radioopaque
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SIDE DISTRIBUTION 
 Right side stones observed in 62 patients and left side stones 
observed in 38 patients. 
Right Left 
62 38 
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LOCATION 
 The stone distribution anatomically was as follows: 60 patients had 
stone in renal pelvis, 20 patients had stone in upper calyx and middle 
calyx and 20 patients had stone in lower calyx with favourable anatomy. 
LOCATION NO. OF PATIENTS 
Pelvis 60 
Upper  and Middle calyx 20 
Lower calyx 20 
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STONE SIZE
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 Among the patients in USG guided group, there were 4 patients in 
size between < 5mm, 17 patients in size 6 – 10mm, 29 patients in stone 
size > 10 mm. 
 Among the patients in fluoro guided group, there were 4 patients in 
size between  5- 10 mm 36 patients in size between 10 – 20mm 6 patients 
in size > 20mm. 
Size USG Fluoroscopy 
 5 4 Nil 
6 – 10mm 17 10 
11 - 20mm 29 40 
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STENTING 
Stone Size >1.5CM were stented, 74% patients were stented and 
26% patients were not stented. 
ESWL with stent ESWL in situ 
74% 26% 
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FRAGMENTATION AND CLEARANCE  
USG GUIDED ESWL  
Size 
mm  
No. of 
Patients 
Radi-
olucent 
Radio 
opaque 
No.  
of 
Shocks 
Stone 
Free 
Frag-
mented 
completely 
Residual 
fragments 
II 
ESWL 
Auxiliary 
Proce-
dures 
< 5 4 2 2 500 - 
1000 
4 - - - - 
6 – 10 17 7 10 1000 - 
1500 
12 3 1 2 - 
11- 20 29 11 18 2500 - 
5000 
19 8 3 2 2 
 
FLUOROSCOPIC GUIDED ESWL  
Size 
mm 
No. of 
Patients 
Radi-
olucent 
Radio 
opaque 
No.  
of 
Shocks 
Stone 
Free 
Frag-
mented 
completely 
Residual 
fragments 
II 
ESWL 
Auxiliary 
Proce-
dures 
< 5 - - - - - - - - - 
6 – 10 10 - 10 1500 - 
2000 
6 3 1 1 - 
11 – 
20 
40 - 40 2500 -
5000 
26 10 4 3 1 
 
USG Guided ESWL 
 Out of 50 cases, both Radiolucent and Radio Opaque stones, mean 
distance between skin – stone < 10 cms, more kidney movement even 
after sedation, CIRF – clinically insignificant residual fragment were the 
selection criteria before placing the patient on gantry.  
 Out of 5 patients of < 5 mm, 2 were Radiolucent and 2 were Radio 
Opaque. No. of shocks ranged between 500 – 1000. All 4 patients were 
stone free.  
 Out of 17 patients of 6 – 10 mm, 7 were Radiolucent and 10 were 
Radio Opaque. No. of shocks ranged between 1000 – 1500. Stone free 
were 12 patients, complete fragmentation was 3 patients, one patient was 
with residual fragment. Two patients underwent II sitting ESWL.   
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 Out of 29 patients of 11 - 20 mm, 11 were Radiolucent and 18 were 
Radio Opaque. No. of shocks ranged between 2500 – 5000 in single or 
double sitting. 19 patients were stone free. 8 were completely fragmented 
3 were with residual fragments. 2 patients underwent II sitting ESWL 
Other two patients underwent Auxiliary  procedures. 
Fluoroscopy Guided ESWL 
 Out of 50 cases, all were Radio Opaque stones, mean distance 
between skin – stone > 10 cms, less kidney movement before or after 
sedation were the selection criteria before placing the patient on gantry.  
 It was very difficult to localise < 5 mm and hence these patients are 
not selected in this group.  
 Out of 10 patients of 6 – 10 mm, all were Radio Opaque. No. of 
shocks ranged between 1500 - 2000. Stone free were 6 patients, 
completely fragmented were 3 patients one patient was with residual 
fragment who underwent II  sitting ESWL.   
 Out of 40 patients of 11 - 20 mm,  No. of shocks ranged between 
2500 – 5000  in single or double sitting. 26 patients were stone free. Ten  
patients were completely fragmented, 4 were with residual fragments  
3 patients underwent II sitting ESWL. One patient underwent Auxiliary 
procedures. 
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Mixed Stones Uric Acid Struvite Stones 
CHEMICAL COMPOSITION  
 
 The chemical composition of post ESWL fragments was obtained 
in 60 patients by chemical dissolution method (qualitative analysis). The 
following table depicts the various chemical compositions. 
 40 patients were not able to retrieve their stones.  
TYPE OF STONE NO. OF 
PATIENTS 
HU 
Mixed Stones (Calcium, Oxalate, 
Phosphate & Uric Acid) 
50 400 – 1000  
Uric Acid  3 600 – 900  
Struvite Stones  7 550 – 750  
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COMPLICATIONS  
MINOR  
 
1. LUTS   - 50 - Conservative management  
2. Hematuria  - 10 - Conservative management  
3. Stent migration   - 2 - Re-positioning (1),  
         removal (1) 
4. steinstrasse   -  2 - URS/ ICL / DJ stenting  
 
NO MAJOR COMPLICATIONS  
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STATISTICS 
AGE GROUP * USG/FLUOROSCOPY 
   Usg/Fluoroscopy  
   1 2 Total 
AGE 
GROUP 
<25 
(1) 
Count 10 9 19 
% within 
USG/FLUOROSCOPY 
20.0% 18.0% 19.0% 
26  
to  
35  (2) 
Count 19 27 46 
% within 
USG/FLUOROSCOPY 
38.0% 54.0% 46.0% 
36  
to  
45  
(3) 
Count 13 13 26 
% within 
USG/FLUOROSCOPY 
26.0% 26.0% 26.0% 
46  
& above  
(4)  
Count 8 1 9 
% within 
USG/FLUOROSCOPY 
16.0% 2.0% 9.0% 
 Total Count 50 50 100 
% within 
USG/FLUOROSCOPY 
100.0% 100.0% 100.0% 
P>0.05  NOT  SIGNIFICANT. 
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SEX * USG/FLUOROSCOPY 
   USG/FLUOROSCOPY 
   1 2 Total 
SEX Male  
(1)  
Count 26 29 55 
% within USG/FLUOROSCOPY 52.0% 58.0% 55.0% 
Fe-
male  
(2)  
Count 24 21 45 
% within USG/FLUOROSCOPY 48.0% 42.0% 45.0% 
 Total Count 50 50 100 
% within USG/FLUOROSCOPY 100.0% 100.0% 100.0% 
 
P=0.546  NOT  SIGNIFICANT.  
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LOCATION * USG/FLUOROSCOPY 
   USG/FLUOROSCOPY 
   1 2 Total 
Location 1 (Renal 
pelvis) 
Count 23 37 60 
% within USG / 
FLUOROSCOPY 
46.0% 74.0% 60.0% 
2 (Lower 
calyx)   
Count 12 8 20 
% within USG /  
FLUOROSCOPY 
24.0% 16.0% 20.0% 
3 (Middle 
calyx)  
Count 7 3 10 
% within USG /  
FLUOROSCOPY 
14.0% 6.0% 10.0% 
4 (Upper 
calyx) 
Count 8 2 10 
% within USG/ 
FLUOROSCOPY 
16.0% 4.0% 10.0% 
 Total Count 50 50 100 
% within USG/ 
FLUOROS COPY 
100.0% 100.0% 100.0% 
P=0.026  SIGNIFICANT. 
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SIZE  * USG/ Fluoroscopy 
   USG/FLUOROSCOPY 
   1 2 Total 
SIZE 
GROUP 
mm  
1 (< 5) Count 4 0 4 
% within 
USG/FLUOROSCOPY 
8.0% .0% 4.0% 
2  (6–10) Count 17 10 27 
% within 
USG/FLUOROSCOPY 
34.0% 20.0% 27.0% 
3 (10– 20)  Count 29 40 69 
% within 
USG/FLUOROSCOPY 
58.0% 80.0% 69.0% 
 Total Count 50 50 100 
% within 
USG/FLUOROSCOPY 
100.0% 100.0% 100.0% 
P=0.023  SIGNIFICANT. 
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RESULTS  - FRAGMENTATION * USG/FLUOROSCOPY 
   USG / FLUOROSCOPY 
   1 2 Total 
Results 1 (stone free)  Count 35 32 67 
% within 
USG/FLUOROSCOPY 
70.0% 64.0% 67.0% 
2 (completely 
fragmented)  
Count 11 13 24 
% within 
USG/FLUOROSCOPY 
22.0% 26.0% 24.0% 
3 (residual 
fragment) 
Count 4 5 9 
% within 
USG/FLUOROSCOPY 
8.0% 10.0% 9.0% 
 Total Count 50 50 100 
% within 
USG/FLUOROSCOPY 
100.0% 100.0% 100.0% 
 
P=0.814  NOT SIGNIFICANT, 
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T-Test 
 
Group Statistics 
 
USG /  
FLUOROSCOPY N Mean 
Std. 
Deviation 
Std. Error 
Mean 
AGE 1 50 34.74 9.852 1.393 
2 50 31.32 6.841 0.967 
 
Group Statistics 
 
USG / 
FLUOROSCOPY N Mean 
Std. 
Deviation 
Std. Error 
Mean 
SIZE mm 1 50 12.24 4.250 .601 
2 50 14.04 3.386 .479 
P=0.021  SIGNIFICANT 
 
Group Statistics 
 
USG / 
FLUOROSCOPY N Mean 
Std. 
Deviation 
Std. Error 
Mean 
NUMBER 
OF SHOCKS 
1 50 2134.50 956.201 135.227 
2 50 2552.00 585.352 82.781 
P=0.010  SIGNIFICANT  
There exists a statistical significant difference between the USG and 
fluoroscopy group with respect to shocks given to respected patients. The mean  
level of number of shocks  for USG- group is 2134.50 which  is less than  
fluoroscopy group.  
Group Statistics 
 USG / 
FLUOROSCOPY 
N Mean Std. Deviation Std. Error Mean 
CTHU 1 50 726.40 161.886 22.894 
2 50 727.20 115.935 16.396 
P=0.977  NOT  SIGNIFICANT 
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DISCUSSION 
 ESWL has revolutionized the treatment strategy of urolithiasis 
world wide and continue to be a major therapeutic modality for treating 
the majority of upper urinary tract stones. It’s non invasive nature along 
with high efficacy has resulted in outstanding patient and surgeon 
acceptance. 
 ESWL is the preferred modality of treatment for renal stones less 
than 2 cm. However stone free rate (SFR) after treatment had never been 
near 100% and in our study it has between the range of  65 – 75 %. 
 The success rate of ESWL is determined by factors such as stone 
factors, clinical factors and anatomic factors. Fragility dependent factors 
are size, composition and density of stone. 
 Regarding size of the stone, approximately 50 – 60 % of all 
Solitary Renal Calculi are less than 10 mm in diameter. (Cass 1995, 
Renner & Rassweiler 199, Logarakis et. al 2000). Treatment result of 
SWL for this substantial group of patients are generally satisfactory and 
independent of stone location and composition. In our study CIRF < 5mm 
are better localised by USG and stone clearance is easily achieved with 
minimum number of shocks in short duration with out sedation. Stone 
free % in this group was almost 100 % in one study.  
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In our study Patients with calculi between 5 – 10mm, both USG 
and Fluoroscopy localization were almost with same stone free results. 
Reduced number of shocks by USG Guided was because of its 
continuous monitoring & frequent adjustment of probe position. 
 Patients with 10 – 20 mm are often treated with SWL as first line 
of management. Stone composition and location also affect the result of 
ESWL for this group of size. In our study the results of USG vs 
fluoroscopy factors influencing the fragmentation and number of shocks 
were obesity, stone–skin mean distance, movement of kidney, 
radiolucency, stent, hydronephrosis. Only in selected patients NCCT was 
done and the HU were within 1000. 
 Morbid obesity, defined as >100 pounds overweight. >200% of 
ideal bodyweight, or body mass index [a value obtained by weight in kg 
divided by height in meters square] greater then 40 posses a number of 
physiological technical challenges to the successful treatment of kidney 
stones [Geblin et al 1995; Fredmen et al 2002]. Factors based on 
morbid obesity are weight limitation on lithotripter table or gantry, 
inability to target stone radiographically or skin to stone distance that 
exceeds the maximum allowable focal distance of the lithotripter. 
Machine with greatest focal length and highest peak pressure should be 
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selected (Hofmann and Stoller 1992). In our study the selection of 
obesity was based on <10 cm placed under USG and >10cm under 
fluoroscopy guided. Localisation and targeting was better by fluoroscopy 
when distance was more. But lesser the distance, good localization with 
continuous monitoring gave quicker results with lesser number of shocks 
in USG guided group.  
 Radiation hazard is a main factor for USG guided ESWL 
nowadays. Radiation hazard is not only for the patient but also for the 
consultant and technician. Health hazard is calculated from the formula 
1/d2. 
   Rib is another factor for localization because of more kidney 
movement with long rib. In our study USG guided was useful by frequent 
change in focal point there by reducing the waste shocks on ribs. 
 Hydronephrosis is prerequisite for PCNL but a negative factor for 
ESWL. In our study calculus with pelviectasis or calyectasis led to 
frequent change in focal point and continuous monitoring reduced the 
number of shocks with early fragmentation. 
 Stone composition- Dretller (1988) first introduced concept of 
stone fragility. Teichman and collegues (1998b) reported that holmium 
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laser in vitro was the most effective lithotrite for fragmenting struvite 
stone and least effective lithotrite for calcium oxalate monohydrate 
stones. Saw and Lingeman (1999) reported that adjusted for size,cystine 
and brushite calculi are the most resistant to SWL followed by calcium 
oxalate monohydrate following in descending order of resistance to 
fragmentation are struvite, calcium oxalate dehydrate and uric acid stones 
(Pittomvils et al, 1994; Sand Lingeman 1999). 
 In our study post ESWL fragments was obtained in 60 patients by 
chemical dissolution method. In our study we found complete 
fragmentation of uric acid and struvite stones in the first sitting. 
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CONCLUSION 
 USG Guided ESWL is preferred option in all renal calculus.  
< 2 cm in renal pelvis, upper calyx and middle calyx, < 1 cm in lower 
calyx. It is a most preferred option in other following conditions like.  
1.  Clinically insignificant Residual fragment  
2.  Paediatric groups.  
3.  Solitary Kidney  
4.  Radiolucent stone  
5.  Skin to stone mean distance < 10 cm.  
6.  Because of radiation hazard.  
 In all group of patient No. of shocks is comparatively is less when 
compared to fluoroscopic guided ESWL.  
 Fluoroscopy guided ESWL in renal calculus is a preferred option 
when it is difficult to localize by USG, Morbid obesity (Skin – stone 
distance > 10 cm in our study.  
 Both ultra sound and fluoroscopic guided ESWL has its own 
advantages and dis-advantages.  
 Wherever USG guided ESWL is available it is the most preferred 
option.  
 Wherever Fluoroscopy guided ESWL is available USG as a 
combined modality is an added advantage.  
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